Cite

HARVARD Citation

    Subbiah, V. et al. (2020). Antitumor activity of lurbinectedin in second-line small cell lung cancer patients who are candidates for re-challenge with the first-line treatment. Lung cancer. pp. 90-96. [Online]. 
  
Back to record